BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23440979)

  • 1. Fine-needle sampling provides appreciable diagnostic yield in lesions of post kala azar dermal leishmaniasis: analysis of four cases from North Eastern India.
    Bandyopadhyay A; Majumdar K; Gangopadhyay M; Koley S
    Diagn Cytopathol; 2014 Jun; 42(6):525-9. PubMed ID: 23440979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
    Singh A; Ramesh V; Ramam M
    Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.
    Sultana A; Zakaria SM; Bhuiyan SI; Habib A; Dey SK; Rahman M; Basher A
    Mymensingh Med J; 2012 Jul; 21(3):529-32. PubMed ID: 22828555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of post kala-azar dermal leishmaniasis in India.
    Tripathy K; Misra A; Mallik R; Misra D; Rout N; Rath J
    Korean J Parasitol; 2010 Sep; 48(3):245-6. PubMed ID: 20877504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable diagnosis of post-kala-azar dermal leishmaniasis (PKDL) using slit aspirate specimen to avoid invasive sampling procedures.
    Verma S; Bhandari V; Avishek K; Ramesh V; Salotra P
    Trop Med Int Health; 2013 Mar; 18(3):268-75. PubMed ID: 23279800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
    Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
    BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in Post-kala-azar Dermal Leishmaniasis.
    Zijlstra EE
    Front Cell Infect Microbiol; 2019; 9():228. PubMed ID: 31417876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time Fluorimetry Loop-Mediated Isothermal Amplification for Diagnosis of Leishmaniasis and as a Tool for Assessment of Cure for Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Gupta R; Negi NS; Singh R; Salotra P
    Am J Trop Med Hyg; 2021 Apr; 104(6):2097-2107. PubMed ID: 33872204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Kala-azar dermal leishmaniasis ( a review of 10 cases).
    Khan HM
    Bangladesh Med Res Counc Bull; 1977 Dec; 3(2):130-6. PubMed ID: 615589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical and histopathological study of macular type of post-kala-azar dermal leishmaniasis.
    Ramesh V; Singh N
    Trop Doct; 1999 Oct; 29(4):205-7. PubMed ID: 10578632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-kala-azar dermal leishmaniasis.
    Zijlstra EE; Musa AM; Khalil EA; el-Hassan IM; el-Hassan AM
    Lancet Infect Dis; 2003 Feb; 3(2):87-98. PubMed ID: 12560194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
    Ganguly S; Saha P; Chatterjee M; Roy S; Ghosh TK; Guha SK; Kundu PK; Bera DK; Basu N; Maji AK
    PLoS Negl Trop Dis; 2015; 9(10):e0004138. PubMed ID: 26485704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.
    Ramesh V; Kaushal H; Mishra AK; Singh R; Salotra P
    BMC Public Health; 2015 Oct; 15():1092. PubMed ID: 26503551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.